It was a busy week for the biotech sector, as the fourth-quarter earnings season is in full swing. While Gilead Sciences, Inc. GILD gained following the earnings beat and upbeat guidance for 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback